Veracyte, inc. (VCYT)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Dec'12
Assets
Current assets:
Cash and cash equivalents

153,132

159,317

195,662

192,647

67,841

77,995

77,846

23,758

27,152

33,891

41,195

46,463

51,506

59,219

31,699

38,993

47,456

39,084

46,116

51,045

25,798

35,014

44,002

57,998

64,237

71,220

15,426

14,002

Accounts receivable

19,091

19,329

23,613

19,626

16,615

13,168

12,262

13,006

13,198

12,716

11,635

11,027

9,125

8,756

6,312

3,387

3,230

3,503

3,520

3,586

2,564

3,050

1,180

1,430

1,191

1,143

714

569

Supplies

6,094

6,806

6,608

5,104

3,768

3,402

3,463

3,049

4,557

5,324

3,760

3,317

3,443

3,475

3,416

3,502

3,652

3,767

3,984

3,976

3,732

3,696

3,350

3,300

2,721

2,567

1,392

1,050

Prepaid expenses and other current assets

3,045

2,235

2,196

2,573

2,392

2,387

1,803

1,822

2,142

1,997

1,617

1,933

2,101

2,057

1,405

1,395

1,618

1,442

3,371

1,735

1,179

1,218

1,711

1,450

1,014

1,477

2,938

710

Deferred tax asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

222

254

300

300

325

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

0

120

120

120

120

120

238

118

118

118

118

70

100

-

-

-

-

50

Total current assets

181,362

187,687

228,079

219,950

90,616

96,952

95,374

41,635

47,049

53,928

58,207

62,860

66,295

73,627

42,952

47,397

56,194

47,914

57,331

60,714

33,691

43,348

50,668

64,178

69,163

76,407

20,470

16,381

Property and equipment, net

8,788

8,933

8,488

8,150

8,114

8,940

8,939

9,035

9,215

9,688

10,281

10,093

10,657

11,480

10,435

10,937

11,272

10,314

6,200

4,211

4,132

4,161

3,792

3,312

3,028

2,952

2,826

2,446

Right-of-use assets - finance lease, net

-

-

619

677

735

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right-of-use assets - operating lease

8,576

8,808

9,033

9,412

9,630

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finite-lived intangible assets, net

63,744

65,019

11,200

11,467

11,733

12,000

12,267

12,533

12,800

13,067

13,333

13,600

13,867

14,133

14,400

14,666

14,933

15,200

15,467

15,733

-

-

-

-

-

-

-

-

Indefinite-lived intangible assets: in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,000

16,000

16,000

-

-

-

-

-

Goodwill

2,725

2,725

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

1,057

-

-

-

-

-

Restricted cash

603

603

603

603

603

603

603

603

603

603

603

603

603

603

603

603

603

603

603

603

-

118

118

118

118

118

118

118

Other assets

1,302

1,437

1,228

1,061

1,049

1,086

837

598

466

326

178

134

127

134

203

172

208

159

195

185

180

155

179

142

145

153

157

122

Total assets

267,100

275,212

260,307

252,377

123,537

120,638

119,077

65,461

71,190

78,669

83,659

88,347

92,606

101,034

69,650

74,832

84,267

75,247

80,853

82,503

55,060

64,839

71,814

67,750

72,454

79,630

23,571

19,067

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

7,665

2,328

5,568

4,061

4,064

2,516

1,175

1,962

3,356

3,853

3,161

2,349

2,611

2,424

3,081

2,705

4,340

5,085

6,644

2,688

6,854

7,397

8,587

8,539

7,214

5,294

5,604

1,888

Accrued liabilities

10,079

13,734

9,760

9,820

8,788

9,186

9,261

8,429

8,483

8,175

8,058

8,450

6,800

9,110

7,189

8,910

7,021

8,689

7,365

7,217

5,396

7,851

6,106

5,128

5,267

7,594

4,416

4,020

Deferred Genzyme co-promotion fee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

227

518

948

1,423

1,897

1,897

1,897

1,897

2,500

2,500

2,500

2,500

2,500

Current portion of long-term debt

-

-

0

0

0

1,357

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

1,420

940

467

-

-

-

Current portion of finance lease liability

-

-

79

156

233

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating Lease, Liability, Current

1,450

1,407

1,365

1,284

1,244

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

583

Total current liabilities

19,194

17,469

16,772

15,321

14,329

13,059

10,436

10,391

11,839

12,028

11,219

10,799

9,411

11,534

10,270

11,842

11,879

14,722

15,432

11,802

14,147

17,145

18,010

17,107

15,448

15,388

12,520

8,991

Long-term debt

748

694

639

585

12,854

23,925

25,192

25,103

25,016

24,938

24,997

24,971

24,944

24,918

24,891

24,671

24,452

4,990

5,002

4,975

4,949

4,923

3,587

4,031

4,467

4,899

4,863

-

Deferred rent, net of current portion

-

-

-

-

-

3,899

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related contingent consideration

5,604

6,088

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

222

254

300

300

325

-

-

-

-

-

Deferred rent, net of current portion

-

-

0

-

0

-

3,953

4,005

4,094

4,170

4,245

4,277

4,373

4,402

4,484

4,566

4,630

4,283

2,386

384

111

149

186

223

260

286

250

61

Operating Lease, Liability, Noncurrent

11,132

11,506

11,872

12,231

12,582

0

79

156

233

308

382

456

528

599

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

252

-

Deferred Genzyme co-promotion fee, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

474

948

1,423

1,364

1,989

2,614

3,239

5,114

Total liabilities

36,678

35,757

29,283

28,137

39,765

40,883

39,660

39,655

41,182

41,444

40,843

40,503

39,256

41,453

39,645

41,079

40,961

23,995

23,042

17,415

19,981

23,465

23,531

22,725

22,164

23,187

21,124

14,166

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Convertible preferred stock, $0.001 par value; 0 and 59,147,999 shares authorized, 0 and 53,084,507 shares issued and outstanding as of December 31, 2013 and December 31, 2012; aggregate liquidation value of $0 and $65,835 as of December 31, 2013 and 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

79,022

63,372

Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.001 par value; 125,000,000 shares authorized, 49,999,923 and 49,625,341 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

50

50

49

48

42

41

41

34

34

34

34

34

34

34

28

28

28

28

27

27

23

23

22

21

21

21

1

1

Additional paid-in capital

488,773

486,090

470,202

462,689

319,733

313,800

310,357

252,284

250,238

248,278

245,430

243,409

241,617

239,631

205,658

203,769

202,079

199,950

198,497

196,829

157,688

156,373

155,141

143,982

142,592

142,071

3,181

1,597

Accumulated deficit

-258,401

-246,685

-239,227

-238,497

-236,003

-234,086

-230,981

-226,512

-220,264

-211,087

-202,648

-195,599

-188,301

-180,084

-175,681

-170,044

-158,801

-148,726

-140,713

-131,768

-122,632

-115,022

-106,880

-98,978

-92,323

-85,649

-79,757

-60,069

Total stockholders’ equity

230,422

239,455

231,024

224,240

83,772

79,755

79,417

25,806

30,008

37,225

42,816

47,844

53,350

59,581

30,005

33,753

43,306

51,252

57,811

65,088

35,079

41,374

48,283

45,025

50,290

56,443

-76,575

-58,471

Total liabilities and stockholders’ equity

267,100

275,212

260,307

252,377

123,537

120,638

119,077

65,461

71,190

78,669

83,659

88,347

92,606

101,034

69,650

74,832

84,267

75,247

80,853

82,503

55,060

64,839

71,814

67,750

72,454

79,630

23,571

19,067